Table 1.
Articles included in the narrative review (n.r.: not relevant).
| Article Title | 1st Author/Year | Patients (n) | Article Type |
|---|---|---|---|
| Long Term Effects of Cocaine on the Heart Assessed by Cardiovascular Magnetic Resonance at 3T | Maceira et al., 2014 [3] | 132 | Cohort Study Prospective |
| Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine | Nguyen et al., 2017 [4] | 267 | Cohort Study Retrospective |
| Improvement in Clinical Outcomes of Patients with Heart Failure and Active Cocaine Use after β-Blocker Therapy | Lopez et al., 2018 [5] |
38 | Cohort Study Retrospective |
| Effect of β-Blocker Therapy on Hospital Readmission and Mortality in Heart Failure Patients With Concurrent Cocaine Use | Egbuche et al., 2018 [6] | 268 | Cohort Study Retrospective |
| Carvedilol Among Patients With Heart Failure With a Cocaine-Use Disorder | Banerji et al., 2019 [7] |
2578 | Cohort Study Retrospective |
| Clinical Outcomes of B-Blocker Therapy in Cocaine-Associated Heart Failure | Lopez et al., 2019 [8] |
72 | Cohort Study Retrospective |
| Detection of Subclinical Myocardial Dysfunction in Cocaine Addicts with Feature Tracking Cardiovascular Magnetic Resonance | Maceira et al., 2020 [9] |
124 | Cohort Study Prospective |
| Outcomes in Patients With Heart Failure Using Cocaine | Garry et al., 2022 [10] |
3131 | Cohort Study Retrospective |
| Effect of Cocaine, Amphetamine, and Cannabis Use Disorders on 30-day Readmissions of Patients with Heart Failure | Thyagaturu et al., 2022 [11] |
978,217 | Cohort Study Retrospective |
| Heavy Burden of Toxic Dilated Cardiomyopathy Among Young Adults: A Retrospective Study and Review of the Literature | Cinq-Mars et al., 2022 [12] |
553 | Cohort Study Retrospective |
| Successful Treatment of Cocaine-Induced Cardiotoxicity with Carvedilol Therapy | Öcal et al., 2015 [13] |
1 | Case Report |
| Severe Heart Failure in a Young Cocaine User | Bekki et al., 2021 [14] |
1 | Case Report |
| Cocaine Cardiotoxicity: A Review of the Pathophysiology, Pathology, and Treatment Options | Phillips et al., 2009 [15] |
n.r. | Review |
| Alcoholic and Cocaine-Associated Cardiomyopathies | Awtry et al., 2010 [16] |
n.r. | Review |
| Influence of Mitochondrion-Toxic Agents on the Cardiovascular System |
Finsterer et al., 2013 [17] |
n.r. | Review |
| Drug-induced Mitochondrial Dysfunction and Cardiotoxicity | Varga et al., 2015 [18] |
n.r. | Review |
| Mechanisms of Cardiotoxicity and the Development of Heart Failure | Lee et al., 2015 [19] |
n.r. | Review |
| Comprehensive Review of Cardiovascular Toxicity of Drugs and Related Agents |
Mladěnka et al., 2018 [20] |
n.r. | Review |
| Epidemiology of Cardiovascular Disease in Young Individuals | Andersson et al., 2018 [21] |
n.r. | Review |
| Cocaine, Heart Failure, and Carvedilol: Triangulating the Safety of β-Blocker Therapy | Page et al., 2019 [22] |
n.r. | Review |
| Beta-Blocker Therapy in Heart Failure Patients with Active Cocaine Use: A Systematic Review | Mann et al., 2020 [23] |
n.r. | Review |
| Drugs of Abuse and Heart Failure | Grubb et al., 2021 [24] |
n.r. | Review |
| Early-Onset Cardiovascular Disease From Cocaine, Amphetamines, Alcohol, and Marijuana |
O’Keefe et al., 2022 [25] |
n.r. | Review |
| Beta-Blocker Treatment of Heart Failure Patients with Ongoing Cocaine Use | Littmann et al., 2013 [26] |
n.r. | Letter to the Editor |
| Safety and Efficacy of Beta-Blockers in Cocaine-Using Patients With Heart Failure | Richards et al., 2018 [27] |
n.r. | Letter to the Editor |
| Beta-Blockers: A Real Antidote for Cocaine-Related Heart Disease? | Barison et al., 2019 [28] |
n.r. | Letter to the Editor |
| Βeta-Blocker Therapy in Cocaine-Associated Heart Failure: Attempting to Mitigate the Risk | Schwier et al., 2019 [29] |
n.r. | Letter to the Editor |